EU-funded project ULTRAPLACAD is developing a low-cost device that can detect the early signs of cancer by analysing blood. The device would allow doctors to screen more patients and provide treatment at an earlier stage of the disease - helping to save lives. The detection of cancer biomarkers – such as a molecule, gene or